Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
8.12M
-
Number of holders
-
1
-
Total 13F shares, excl. options
-
100
-
Shares change
-
-2.09M
-
Total reported value, excl. options
-
$387
-
Value change
-
-$8.08M
-
Number of sells
-
-28
-
Price
-
$3.87
Significant Holders of LUMOS PHARMA INC - Common Stock (LUMO) as of Q4 2024
28 filings reported holding LUMO - LUMOS PHARMA INC - Common Stock as of Q4 2024.
LUMOS PHARMA INC - Common Stock (LUMO) has 1 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 100 shares
of 8.12M outstanding shares and own 0% of the company stock.
Largest 10 shareholders include JONES FINANCIAL COMPANIES LLLP (0 shares), West Financial Advisors, LLC (0 shares), Key Financial Inc (0 shares), Private Advisor Group, LLC (0 shares), BlackRock, Inc. (0 shares), Paladin Advisory Group, LLC (0 shares), Bank of New York Mellon Corp (0 shares), Greenwich Wealth Management LLC (0 shares), Wealth Advisors of Iowa, LLC (0 shares), and Live Oak Investment Partners (0 shares).
This table shows the top 1 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.